A 24-Year-Old Woman With Precipitous Respiratory Failure After Lung Transplantation

Chest. 2018 Mar;153(3):e53-e56. doi: 10.1016/j.chest.2017.08.020.

Abstract

A 24-year-old woman with ΔF508/Y1092X cystic fibrosis (CF) complicated by severe obstructive lung disease (FEV1 of 30% predicted) was admitted for IV antibiotics for planned sinus surgery resulting from severe chronic sinusitis causing frequent exacerbations and declining lung function. She had persistent airway infection with multidrug-resistant Pseudomonas aeruginosa, methicillin-resistant Staphylococcus aureus, and growth of a fungus presumed to be an airway colonizer, identified as Stephanoascus ciferrii 1 year before presentation. Two days after surgery, she developed acute respiratory failure requiring mechanical ventilation. On day 4 of mechanical ventilation, venovenous-extracorporeal membrane oxygenation (VV-ECMO) was initiated for refractory respiratory failure. The following day, she was listed for bilateral lung transplant and was transplanted 4 days later. Following transplantation, she was decannulated from ECMO; however, over the next 12 hours, oxygenation deteriorated requiring reinstitution of VV-ECMO for presumed severe primary graft dysfunction. Despite treatment with broad spectrum antimicrobial coverage with piperacillin/tazobactam, ciprofloxacin, linezolid, micafungin, voriconazole, and ganciclovir, she failed to improve and developed complex bilateral pleural effusions.

Publication types

  • Case Reports

MeSH terms

  • Antifungal Agents / therapeutic use*
  • Cryptococcosis / drug therapy*
  • Cryptococcosis / microbiology*
  • Cryptococcus / isolation & purification*
  • Cystic Fibrosis / complications
  • Cystic Fibrosis / surgery*
  • Extracorporeal Membrane Oxygenation
  • Female
  • Humans
  • Immunocompromised Host
  • Lung Transplantation / adverse effects*
  • Respiration, Artificial
  • Respiratory Distress Syndrome / drug therapy*
  • Respiratory Distress Syndrome / microbiology*
  • Thoracic Surgery, Video-Assisted
  • Young Adult

Substances

  • Antifungal Agents